A Ferrous‐Supply‐Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy
Small · 2026-10 · 22 (55)
DOI: 10.1002/smll.74925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 30.07.2026. Verfasst von Dun Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Central South University, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Nanoparticles, RNA Interference, Lipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Targeting iron‐dependent ferroptosis with siRNA has emerged as a promising strategy for cancer treatment. The concept of ferrous‐supply regeneration, inspired by electro‐Fenton technology, has also gained interest as a non‐apoptotic approach to induce ferroptosis. However, integrating both strategies into a single lipid nanoparticle (LNP) remains challenging. To address this, we developed ALSF, a novel LNP in which DSPC is replaced with arachidonic acid (AA) to enable co‐delivery of Glutathione Peroxidase 4‐siRNA (GPX4‐siRNA) and Fe 3 + . ALSF facilitates acid‐ and H 2 O 2 ‐dependent iron recycling, continuously regenerating Fe 2 + to drive ROS production, while GPX4‐siRNA silences GPX4 to induce lipid peroxidation (LPO) and ferroptosis. Elevated H 2 O 2 levels in cancer cells promote selective iron recycling, lysosomal disruption, and siRNA escape, enabling effective gene knockdown at lower doses. In vivo, ALSF suppressed tumor growth in a C918 xenograft model with favorable biosafety. This study is the first to integrate a ferrous‐supply‐regeneration system with siRNA into a single LNP platform, offering a selective ferroptosis‐inducing strategy for ocular cancers and other ferroptosis‐sensitive malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Central South University, Hunan, People's Republic of China.
- R&D, Rayzon Medical Technology Co., Ltd., Hunan, People's Republic of China.
- Department of Pharmacology Xiangya School of Pharmacy, Central South University, Hunan, People's Republic of China.
- Institute of Clinical Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan, China.
ORCID-Profile: Dun Hu, Jun-Lin Jiang, Shan Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hu, D., Xu, Y. H., Peng, D., Tan, Q., Jiang, J. L., Nie, S. D., & Wang, S. (2026). A Ferrous‐Supply‐Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy. Small, 22(55). https://doi.org/10.1002/smll.74925
Vancouver
Hu D, Xu YH, Peng D, Tan Q, Jiang JL, Nie SD, et al. A Ferrous‐Supply‐Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy. Small. 2026;22(55). doi:10.1002/smll.74925
BibTeX
@article{Hu2026,
author = {Hu, Dun and Xu, Yun-Hua and Peng, Dan and Tan, Qi and Jiang, Jun-Lin and Nie, Sheng-Dan and Wang, Shan},
title = {A Ferrous‐Supply‐Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy},
journal = {Small},
year = {2026},
volume = {22},
number = {55},
doi = {10.1002/smll.74925}
}
EUVIMED